Antral Follicle Count

If you have ever wondered how many eggs you have left, this is the test that gives you a direct visual answer. A trained sonographer counts the small follicles inside each of your ovaries on a transvaginal ultrasound. The number reflects how many eggs your body can recruit in the months ahead and how your ovaries are likely to respond if you ever pursue fertility treatment.

Unlike a blood marker, AFC (antral follicle count) lets you and your clinician see what is actually inside your ovaries on a given day. It is one of the two leading measures of ovarian reserve, alongside the blood test AMH (anti-Mullerian hormone), and the two together give the most complete picture of your fertility window.

What This Count Actually Captures

AFC is the total number of small follicles measuring 2 to 10 millimeters across in both ovaries, counted by transvaginal ultrasound. Each of those follicles holds an immature egg that could potentially mature in an upcoming cycle. The number you see reflects what specialists call the recruitable pool, meaning the eggs available for development in the near term.

The count correlates with the size of the deep primordial follicle pool, which is the true underlying egg reserve in the ovary. Research comparing AFC and AMH to tissue samples from premenopausal women showed both markers track the primordial pool, making AFC a useful, non-invasive proxy for the deeper biology you cannot see directly. The correlation is generally stronger in older women than in younger ones, so the relationship is not perfectly linear at every age.

The same study showed that AMH and AFC together act as the two most trusted surrogates for what is left in the ovary. They are not interchangeable with egg quality, which depends mostly on your age. AFC tells you how many eggs, not how good they are.

How AFC Is Done

A high-frequency transvaginal probe (at least 7 megahertz) is moved across each ovary in two planes. Every round dark structure measuring 2 to 10 millimeters across is counted as an antral follicle. The whole process usually takes a few minutes per ovary.

The traditional and still standard recommendation from the American Society for Reproductive Medicine is to measure AFC during the early follicular phase, typically cycle days 2 through 5. Newer evidence shows that the predictive value of the count is maintained on other cycle days as well. A study of 410 women preparing for IVF (in vitro fertilization) found that random AFC done outside menstruation correlated well with the formal baseline count and predicted oocyte yield equally well. Early follicular timing remains the standardized approach, but a scan done off-cycle still gives you useful information.

Some clinics now use 3D ultrasound or AI-assisted analysis to standardize counts, and at-home virtual transvaginal scans guided remotely by a technologist have been shown in a randomized trial of 56 women to be equivalent to in-clinic scans for measuring ovarian reserve, with higher patient satisfaction.

Predicting Your Response to Fertility Treatment

AFC is among the strongest predictors of how your ovaries will respond to stimulation drugs in IVF. If you are considering treatment, this number directly shapes the protocol your doctor would choose.

A meta-analysis comparing AFC to basal FSH (follicle-stimulating hormone) for predicting poor ovarian response in IVF found AFC was substantially more accurate. Studies of women undergoing IVF have shown that AFC predicts whether you will produce few eggs (poor response) with high accuracy. A retrospective analysis of 89,002 IVF cycles confirmed that AFC and AMH combined with age offer a reliable forecast of poor response.

What this means for you: if you are considering egg freezing or IVF, AFC gives you a realistic preview of how many eggs you can expect to retrieve per cycle, which directly affects how many cycles you might need.

AFC and Polycystic Ovary Syndrome

An unusually high AFC can signal polycystic ovarian morphology, the structural ovarian pattern seen in PCOS (polycystic ovary syndrome). The 2023 International Evidence-Based PCOS Guidelines, endorsed by the Endocrine Society, ESHRE, and ASRM, define polycystic ovarian morphology in adult women as a follicle number per ovary of 20 or more on a high-frequency transvaginal ultrasound. This is lower than the 25-or-more threshold proposed by an earlier 2014 Androgen Excess and PCOS Society task force, which the newer guidelines have superseded.

An analysis of 1,447 adult women looking at how a 25-follicle cutoff would change PCOS classification found that women excluded by the higher threshold still had worse metabolic and hormonal patterns than healthy controls. That work helped support the shift toward a lower cutoff, and the current 20-follicle threshold reflects the more sensitive approach now used internationally.

A high AFC also flags increased risk of ovarian hyperstimulation syndrome (OHSS) during IVF. A study of 2,699 women with PCOS undergoing IVF identified AFC as a strong marker of OHSS severity, which is why doctors adjust stimulation doses downward when AFC is high.

Endometriosis and Ovarian Damage

A meta-analysis pooling multiple studies found that women with endometriosis had significantly reduced AFC compared with women without, along with lower AMH and higher FSH. The effect was strongest in women with ovarian endometriomas and in advanced disease.

Surgery to remove ovarian endometriomas (cystectomy) can further reduce ovarian reserve. Studies of women with endometrioma have shown accelerated decline in AMH after surgery, and a randomized study comparing surgical techniques in 48 women found cystectomy reduced AFC and ovarian volume more than coagulation.

What this means for you: if you have known endometriosis or are considering surgery for an endometrioma, knowing your AFC before any procedure gives you a baseline to weigh against the risk of losing reserve.

After Cancer Treatment

Chemotherapy can permanently lower your AFC. A study of 71 women with breast cancer showed significant decreases in AMH, AFC, and ovarian volume after systemic chemotherapy. A large analysis of 3,904 female childhood cancer survivors confirmed that cyclophosphamide, procarbazine, and abdominal or pelvic radiotherapy were each associated with abnormal ovarian reserve markers years after treatment.

A prospective cohort study in 242 young women with breast cancer found that adding the drug goserelin during chemotherapy helped protect ovarian reserve and improved recovery rates afterward. Subsequent randomized trials including POEMS, OPTION, and the Zong trial published in JAMA Oncology have also shown protective effects on ovarian function. If you are facing cancer treatment, AFC measured before treatment can guide fertility preservation decisions.

Connections to Heart and Aging Health

Emerging research suggests ovarian reserve markers may relate to broader health beyond fertility. A cross-sectional study of 2,338 premenopausal women in the population-based PREVEND study found that women with very low AMH levels had higher cardiovascular disease risk. A separate study of 322 healthy reproductive-age women in the OVA cohort found that baseline AMH and AFC were positively associated with measures of blood vessel function.

A study of 70 women measuring granulosa cell DNA methylation found that lower ovarian reserve was significantly associated with an accelerated pace of biological aging and higher risk of cardiovascular and metabolic disease. This is preliminary work, but it suggests AFC may eventually become useful beyond fertility planning.

Why One Reading Is Not Enough

Even with a careful technician, AFC varies more between cycles than blood-based AMH. A study comparing the cycle-to-cycle variability of both markers in 121 women found AFC had more individual variation than AMH, and a 2023 study tracking both markers over four consecutive cycles confirmed AMH was more reproducible. In experienced centers, intercycle variability of AFC is still considered low, but it is real. High counts are also harder to count consistently, and reproducibility declines when there are many follicles to track.

Get a baseline scan, then retest in 6 to 12 months if you are making fertility decisions or watching for change. If you are considering egg freezing or have a condition that may affect ovarian reserve, repeat at least annually. Pair AFC with an AMH blood test on the same visit so you have two independent signals; when they agree, your confidence in either is much higher.

An age-related nomogram built from data on 3,821 women showed AFC follows a predictable pattern, peaking in the early twenties and declining steadily afterward. Comparing your number against age-specific percentiles tells you more than the raw count alone.

When Results Can Be Misleading

• Operator variability: AFC depends on the person doing the scan. Reproducibility declines when there are many follicles to count, and high-count ovaries (often in PCOS) are the hardest to measure consistently.
• Equipment quality: Lower-frequency probes miss small follicles. The recommended high-frequency probe (at least 7 megahertz) detects more follicles, which is why older studies using older equipment used different thresholds.
• Recent surgery on the ovary: If you have had a recent cystectomy or other ovarian surgery, your AFC may temporarily reflect surgical disruption rather than your true baseline reserve.
• Hormonal contraception: The pill, patch, ring, or hormonal IUD can suppress small follicles and lower the count, masking your true reserve.
• Cycle phase quirks: Although AFC retains predictive value across the cycle, a large dominant follicle later in the cycle can crowd out smaller ones from view on a given day. The early follicular phase remains the standardized window, and a repeat scan on a different day clarifies the picture if a single reading looks unexpected.

What to Do If Your AFC Is Unexpected

If your AFC is lower than expected for your age, pair it with an AMH blood test and a day-3 FSH and estradiol panel. When all three point in the same direction, the signal of diminished ovarian reserve is much stronger than any single number alone. If they disagree, AFC is generally considered a strong predictor of how your ovaries will respond to stimulation.

If your AFC is higher than expected, especially with irregular cycles, acne, or excess hair growth, ask for an evaluation that includes testosterone, SHBG (sex hormone-binding globulin), and an LH-to-FSH ratio to assess for PCOS. A reproductive endocrinologist can pull the pieces together and tell you whether the high count is benign polycystic ovarian morphology or part of a metabolic pattern that needs attention.

For most women, an unexpected AFC is a prompt to gather information, not to panic. Combine the result with your age, your family history, your reproductive plans, and a follow-up scan to see whether the number shifts.